Millendo Therapeutics Inc (NASDAQ:MLND)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - MLND

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - MLND

  • Market Cap$34.390m
  • SymbolNASDAQ:MLND
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS60040X1037

Company Profile

Millendo Therapeutics Inc is a late-stage biopharmaceutical company focused on developing novel treatments for orphan endocrine diseases. Its lead asset, livoletide, is an unacylated ghrelin analogue being developed for the treatment of Prader-Willi syndrome (PWS), a rare genetic disease characterized by hyperphagia, a chronic unrelenting hunger, that leads to obesity, metabolic dysfunction, reduced quality of life and early mortality. The company is also developing nevanimibe, an ACAT1 inhibitor for the treatment of two orphan adrenal diseases: classic congenital adrenal hyperplasia (CAH) and endogenous Cushing's syndrome (CS).OvaScience Inc is a part of the healthcare sector. Its core area of operation involves commercialization of new fertility treatments for women using its patented technology.

Latest MLND news

Currently there for this company. Visit our news hub for other news .